限制性股票激励计划
Search documents
新澳股份: 国浩律师(杭州)事务所关于新澳纺织股份有限公司2023年限制性股票激励计划部分限制性股票回购注销实施之法律意见书
Zheng Quan Zhi Xing· 2025-09-02 16:14
Core Viewpoint - Zhejiang Xin'ao Textile Co., Ltd. is implementing a partial repurchase and cancellation of restricted stocks as part of its 2023 incentive plan, which complies with relevant laws and regulations [2][7]. Group 1: Repurchase Cancellation Details - The repurchase cancellation is based on the incentive plan's provisions, allowing the company to repurchase stocks from individuals who do not meet performance criteria [4][5]. - A total of 8 individuals are involved in this repurchase cancellation, with the stocks expected to be repurchased by September 5, 2025 [5]. - The company has opened a dedicated securities account for the repurchase and submitted the necessary applications to the China Securities Depository and Clearing Corporation [5]. Group 2: Legal Compliance and Procedures - The legal opinion confirms that the repurchase cancellation adheres to the Company Law, Securities Law, and relevant regulations, and that necessary procedures have been followed [6][7]. - The company has fulfilled its information disclosure obligations regarding the repurchase, in accordance with legal requirements [6][7]. - The company must still complete the capital reduction and stock cancellation procedures as per the Company Law and its articles of association [7].
优彩资源: 关于调整2025年限制性股票激励计划相关事项的公告
Zheng Quan Zhi Xing· 2025-09-02 16:14
Core Viewpoint - The company has adjusted its 2025 Restricted Stock Incentive Plan, reducing the number of incentive recipients from 59 to 58 and decreasing the total number of shares granted from 1.371553 million to 1.356553 million due to compliance issues with stock trading by one of the incentive recipients [1][3][4] Summary by Sections Approval Procedures - The company held its fourth board meeting and the eighth supervisory board meeting on September 2, 2025, where it approved the adjustment of the 2025 Restricted Stock Incentive Plan [1] - The board reviewed and approved the draft of the incentive plan and its management measures, along with the authorization for the board to handle related matters [1][2] Adjustment Details - During the self-inspection period from February 11, 2025, to August 11, 2025, four incentive recipients were found to have traded company stock [2] - Three recipients traded based on their own market judgment before knowing about the incentive plan, while one recipient traded after being aware of the plan but claimed limited knowledge of its specifics [2][3] - The company decided to cancel the qualification of the one recipient who traded after being informed of the plan [3] Impact of Adjustments - The adjustments will not have a substantial impact on the company's financial status or operational results [3][4] Opinions from Committees - The Compensation and Assessment Committee and the Supervisory Board both agreed that the adjustments comply with relevant laws and regulations and do not harm the interests of the company or its shareholders [4] Legal Opinion - The legal opinion from Shanghai Jinghe Law Firm confirmed that the adjustments and grants have obtained necessary approvals and comply with relevant regulations [4]
威高血净: 山东威高血液净化制品股份有限公司2025年第一次临时股东大会会议资料
Zheng Quan Zhi Xing· 2025-09-02 16:14
Meeting Overview - The company is holding a temporary shareholders' meeting to discuss various proposals, including the 2025 restricted stock incentive plan [1][2] - The meeting will follow specific procedures to ensure order and efficiency, with provisions for shareholder participation and questioning [1][2] Agenda Items - Proposal 1: Discussion on the company's 2025 interim dividend plan, which aims to enhance shareholder returns [2][3] - Proposal 2: Review of the 2025 restricted stock incentive plan draft and its summary [2][6] - Proposal 3: Examination of the implementation assessment management measures for the 2025 restricted stock incentive plan [2][7] - Proposal 4: Authorization for the board to handle matters related to the 2025 restricted stock incentive plan [2][9] - Proposal 5: Cancellation of the supervisory board and amendments to the company's business scope and articles of association [2][11] - Proposal 6: Development and revision of certain governance systems [2][12] - Proposal 7: Review of candidates for the second board's independent directors and their annual allowances [2][13] Dividend Proposal - The company proposes a mid-year dividend not exceeding 30% of the net profit attributable to shareholders for 2025 [3][4] - The proposed cash dividend is 1.6 yuan per 10 shares, totaling approximately 65.82 million yuan, which represents 29.89% of the net profit for the first half of 2025 [5][6] Restricted Stock Incentive Plan - The company aims to implement a restricted stock incentive plan to attract and retain talent, aligning the interests of shareholders, the company, and core team members [6][7] - The plan's details will be disclosed on August 28, 2025, and it has been approved by the board and supervisory committee [7][9] Governance Changes - The company plans to abolish the supervisory board and amend its articles of association to comply with updated regulations [11] - Several governance systems will be revised to enhance operational standards and compliance with regulatory requirements [12] Independent Director Nomination - The company proposes to nominate Zhang Zhenhua as an independent director, with an annual allowance of 150,000 yuan [13][14] - Zhang Zhenhua meets all qualifications and independence criteria as per relevant regulations [14][15]
天佑德酒: 关于2023年限制性股票激励计划部分限制性股票回购注销完成的公告
Zheng Quan Zhi Xing· 2025-09-02 13:11
Core Viewpoint - The company has completed the repurchase and cancellation of a portion of restricted stock options under its 2023 incentive plan, totaling 2.895 million shares, which represents 30.67% of the total granted shares and 0.60% of the company's total share capital [1][2][3]. Summary by Sections Repurchase and Cancellation Details - The repurchase was initiated due to one incentive recipient leaving the company and the failure to meet performance conditions for the second release period, resulting in a total of 289,500 shares being repurchased and canceled [2][7]. - The repurchase price was set at 7.12 yuan per share, totaling approximately 21.09 million yuan, which includes both principal and interest [8][9]. Company Meetings and Approvals - The company held several board and supervisory meetings to approve the repurchase and cancellation of the restricted stock, ensuring compliance with internal regulations and obtaining necessary legal opinions [3][4][5]. - The decision was made public through various channels, including the company's announcements on the Giant Tide Information Network [2][3]. Impact on Share Capital - Following the repurchase, the company's registered capital decreased from 482,002,974 yuan to 479,107,974 yuan, and the total number of shares reduced from 482,002,974 to 479,107,974 [11][12]. - The company confirmed that this repurchase will not affect the implementation of the incentive plan or its financial status, and the share distribution remains compliant with listing requirements [11][12].
新澳股份拟回购注销19.35万股限制性股票,预计9月5日完成
Xin Lang Zheng Quan· 2025-09-02 11:14
Summary of Key Points Core Viewpoint - The recent announcement by Xin'ao Co., Ltd. regarding the repurchase and cancellation of restricted stock under its 2023 incentive plan has attracted market attention, raising questions about the reasons behind this decision and its potential impact on the company. Group 1: Reasons for Repurchase and Cancellation - The repurchase and cancellation of restricted stock is due to the failure of certain incentive recipients to meet personal performance assessments or their retirement or departure from the company without meeting the conditions for lifting restrictions. A total of 193,500 shares will be repurchased from 8 individuals [1]. - After the repurchase, the remaining restricted stock under the incentive plan will amount to 9,638,700 shares [1]. Group 2: Repurchase Arrangement - The company has opened a dedicated repurchase securities account with China Securities Depository and Clearing Corporation Limited, Shanghai Branch, and has submitted the necessary application for the repurchase and cancellation [2]. - The completion of the repurchase is expected by September 5, 2025, after which the company will proceed with the required business registration changes [2]. Group 3: Compliance with Procedures - On June 17, 2025, the company held its 20th meeting of the sixth board of directors, where it approved the proposal to adjust the repurchase price and cancel part of the restricted stock. This proposal was reviewed and approved by the Compensation and Assessment Committee [3]. - A temporary shareholders' meeting was convened on July 4, 2025, to review and approve related proposals [3]. Group 4: Information Disclosure - The company disclosed relevant resolutions and announcements on June 18 and July 5, 2025, ensuring compliance with information disclosure obligations [4]. - As of the date of the legal opinion, the disclosure period has been completed for 45 days, during which no creditors have requested early debt repayment or guarantees [4]. - The legal firm Guohao (Hangzhou) believes that the repurchase and cancellation comply with relevant laws and regulations, and the necessary procedures and information disclosures have been fulfilled [4].
洁雅股份: 安徽天禾律师事务所关于铜陵洁雅生物科技股份有限公司2025年限制性股票激励计划首次授予事项之法律意见书
Zheng Quan Zhi Xing· 2025-09-02 10:24
Core Viewpoint - The legal opinion letter from Anhui Tianhe Law Firm confirms that Tongling Jieya Biotechnology Co., Ltd. has complied with relevant laws and regulations regarding its 2025 Restricted Stock Incentive Plan, including necessary approvals and authorizations for the initial grant of restricted stock [1][3][4]. Summary by Sections Approval and Authorization of Grant - The Compensation and Assessment Committee and the Board of Directors have approved the draft of the 2025 Restricted Stock Incentive Plan and related proposals [3][4]. - The company has fulfilled necessary approval and authorization procedures for the grant of restricted stock [4][5]. Basic Information of the Grant - The initial grant date for the restricted stock is set for September 2, 2025, with a total of 1,498,000 shares to be granted to 10 incentive recipients [4][5]. - The grant date complies with the regulations, being within 60 days of the shareholders' meeting approval [5]. Recipients of the Grant - The distribution of the granted shares among the recipients is as follows: - Directors and senior management will receive 38.46% of the total shares, while other incentivized personnel will receive 43.85% [6]. - The total number of shares granted to the 10 recipients is 1,498,000, with a reserved portion of 322,000 shares [6]. Conditions for Granting - Recipients must meet specific conditions to be eligible for the restricted stock, including no negative audit opinions in the last fiscal year and no legal restrictions on participating in stock incentives [7][8]. - The company has confirmed that all conditions for granting the restricted stock have been met [8]. Conclusion - The legal opinion concludes that all necessary approvals, grant dates, recipient qualifications, and conditions have been satisfied, ensuring compliance with the relevant regulations [8].
洁雅股份: 关于向激励对象首次授予限制性股票的公告
Zheng Quan Zhi Xing· 2025-09-02 10:24
Core Viewpoint - The company has approved the first grant of restricted stock under its 2025 Restricted Stock Incentive Plan, granting 1,498,000 shares at a price of 12.63 yuan per share to 10 eligible recipients, with the grant date set for September 2, 2025 [1][10][14]. Summary by Sections Incentive Plan Overview - The 2025 Restricted Stock Incentive Plan aims to motivate directors, senior management, and other key personnel deemed necessary for incentivization [1][4]. - The total number of shares granted is 1,498,000, which represents 82.31% of the total incentive plan [3][11]. Grant Details - The grant includes 1,498,000 shares to 10 recipients, with 700,000 shares allocated to directors and senior management, and 798,000 shares to other incentivized personnel [3][11]. - A reserve of 322,000 shares (17.69% of the total) is set aside for future grants [3][11]. Vesting Conditions - The vesting of the restricted stock is contingent upon meeting specific performance targets over three years, with annual assessments [6][7]. - The performance targets are set as follows: - 2025: Revenue growth of at least 25% compared to 2024 - 2026: Revenue growth of at least 50% compared to 2024 - 2027: Revenue growth of at least 100% compared to 2024 [6][7]. Approval Process - The plan has undergone necessary approvals, including reviews by the Compensation and Assessment Committee and the Board of Directors [9][10]. - The company has confirmed that all grant conditions have been met, ensuring compliance with relevant regulations [10][14]. Financial Impact - The fair value of the restricted stock will be calculated using the Black-Scholes model, and the associated costs will be recognized over the vesting period [11][12]. - The estimated total expense for the first grant will impact the company's net profit across the years 2025 to 2028 [12]. Compliance and Legal Review - A legal opinion confirms that the grant complies with all applicable laws and regulations, and the eligibility of the recipients has been verified [14][15].
洁雅股份: 2025年限制性股票激励计划首次授予部分激励对象名单(首次授予日)
Zheng Quan Zhi Xing· 2025-09-02 10:24
Group 1 - The incentive plan involves the allocation of restricted stocks among various incentive recipients, with a total of 182,000 shares granted, representing 1.62% of the company's total share capital [1] - The distribution of granted rights includes 70,000 shares (38.46%) for directors and senior management, and 79,800 shares (43.85%) for other personnel deemed necessary for motivation [1] - A reserved portion of 32,200 shares (17.69%) is also included in the incentive plan, bringing the total granted rights to 182,000 shares [1] Group 2 - The company will disclose relevant information about the incentive recipients in a timely and accurate manner after receiving clear opinions from the Compensation and Assessment Committee and legal counsel [2] - The list of other personnel deemed necessary for motivation by the board of directors is also mentioned, indicating a structured approach to employee incentives [2]
凯格精机: 董事会薪酬与考核委员会与监事会关于公司2025年股权激励计划授予激励对象名单公示情况说明及核查意见
Zheng Quan Zhi Xing· 2025-09-02 10:12
证券代码:301338 证券简称:凯格精机 公告编号:2025-032 股份有限公司 2025 年限制性股票激励计划激励对象名单公示》,对公司本次激 励对象名单予以公示,公示时间为 2025 年 8 月 15 日至 2025 年 8 月 24 日。 截止公示期满,公司董事会薪酬与考核委员会与监事会未收到任何人对本次 激励计划激励对象提出的异议。 董事会薪酬与考核委员会与监事会 关于公司 2025 年限制性股票激励计划激励对象名单 公示情况说明及核查意见 本公司及董事会薪酬与考核委员会、监事会全体成员保证信息披露的内容真 实、准确、完整,没有虚假记载、误导性陈述或重大遗漏。 东莞市凯格精机股份有限公司(以下简称"公司")于 2025 年 8 月 15 日召 开第二届董事会第十六次会议、第二届监事会第十五次会议审议通过了《关于< 东莞市凯格精机股份有限公司 2025 年限制性股票激励计划(草案)>及其摘要的 议案》等相关议案。具体内容详见公司于 2025 年 8 月 15 日在巨潮资讯网 (www.cninfo.com.cn)上披露的相关公告。 根据《中华人民共和国公司法》(以下简称"《公司法》")、《中华人民 ...
洁雅股份: 第六届董事会第四次会议决议公告
Zheng Quan Zhi Xing· 2025-09-02 10:12
Group 1 - The board of directors of Tongling Jieya Biotechnology Co., Ltd. held its fourth meeting of the sixth session on September 2, 2025, via communication, with all members ensuring the accuracy and completeness of the disclosed information [1] - The board approved the first grant of the 2025 restricted stock incentive plan, agreeing to grant 1,498,000 shares at a price of 12.63 yuan per share to 10 eligible incentive objects, with the grant date set for September 2, 2025 [2] - The voting results for the resolution were 4 votes in favor, 0 against, and 0 abstentions, with certain directors recusing themselves from the vote due to conflicts of interest [2]